Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 08-2019 | 05-2019 | 11-2018 | |
| Sales | 10,580 | 0 | 0 |
| Gross Profit | 10,580 | 0 | N/A |
| Operating Expenses | 13,192 | 0 | 0 |
| Operating Income | -2,612 | N/A | N/A |
| Other Income | 195 | 0 | 0 |
| Pre-tax Income | -2,417 | 0 | 0 |
| Income Tax | 10 | 0 | N/A |
| Net Income Continuous | -2,427 | 0 | N/A |
| Net Income | $-2,427 | $0 | $N/A |
| EPS Basic Total Ops | -0.66 | N/A | N/A |
| EPS Basic Continuous Ops | -0.66 | N/A | N/A |
| EPS Diluted Total Ops | -0.66 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.66 | N/A | N/A |
| EBITDA(a) | $-2,059 | $N/A | $N/A |